PICUHAMs- PICUNCT07320196
Smart Mind Maps in Promoting Safe Administration of High-Alert Medications
A study testing smart mind mapsde in people with PICU and Nurses, run by Mansoura University.
Trial summary
In PICU setting, drug administration, monitoring, and prescribing errors made up most cases (54%) of MEs . Emphasizes these issues requires a multifaceted approach, including staff training, creation of innovative cognitive frameworks, use of electronic prescribing systems, and the promotion of a safety-awareness… Read more about this study
- Who is it for?
- Any age
- What is being tested?
- smart mind mapsde
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- No sites listed yet
- Study dates
- 4 Jan 2026to Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Nurses on duty in the PICU (who directly handled HAM) irrespectively to their age, sex, educational level.
Who cannot join
- Nurses who do not handle with HAM
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
doaa osman ibrahim doaa ibrahim- assistant lecturer, assistant lecturer contact
About this study
Official title: The Effectiveness of Smart Mind Maps in Promoting Safe Administration of High-Alert Medications Among Nurses in the Pediatric Intensive Care Unit
In PICU setting, drug administration, monitoring, and prescribing errors made up most cases (54%) of MEs . Emphasizes these issues requires a multifaceted approach, including staff training, creation of innovative cognitive frameworks, use of electronic prescribing systems, and the promotion of a safety-awareness within healthcare settings. Recently, mind mapping has been applied in the field of nursing education as an advanced conceptual tool. It uses a technique of combining drawings with words to build memory associations between a topic keyword and image, color, or other link allowing learners to effectively store and extract information
Read the detailed description
This study aims to evaluate the effectiveness of smart mind maps in promoting safe administration of high-alert medications among nurses in the pediatric intensive care unit. Designing a mind map using AI holds significant value for nurses working in the PICU. AI-powered mind maps can help nurses organize complex patient information more efficiently, enabling quicker decision-making and improved care planning. By integrating AI, the mind map can automatically update with real-time data, alert nurses to critical changes, and even suggest evidence-based interventions. This not only enhances patient safety and care quality but also reduces cognitive load and streamlines communication among the healthcare team .
- Being tested
- smart mind mapsde
- Keywords
- HAMs, PICU, Nurses, Safe administration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
smart mind mapsdeOther
designing a smart mind maps as an advanced conceptual tool to help nurses understand well about HAMs
| Study group | Role | What they receive |
|---|---|---|
| one group pretest/post test | Experimental | PICU nurses who directly handled HAM Receives: Other: smart mind mapsde |
What is being measured
The primary outcome is the main question the study is designed to answer.
Tool I: A Structured Assessment Questionnaire
It will be developed by the researcher which will consist of two parts:
Part 1: Socio-demographic Characteristics and Professional Data of Studied Nurses part 2: Knowledge Assessment Tool on AI and Mind Mapping for Nurses (pre/posttest)
Measured: 2 weeks
Tool II: Nurses' Knowledge Regarding Safe Use of High-Alert Medications (HAMs)
It will be developed to collect data necessary for evaluating nurses' knowledge related to safe use of high-alert medications. The assessment will encompass key domains such as the definition and classification of HAMs, safety precautions during drug administration (including delivery routes and dosage accuracy), and drug regulation (including proper storage, documentation, and handling procedures).
Measured: 1 month
Tool III: Observational Checklist for Safe Handling of High Alert Medications
It will be developed by the researcherto objectively assess nurses' practices related to the safe handling of high-alert medications in PICUs according to the international recognized guidelines and evidence-based protocols.
Measured: 2 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jan 2026
- Study start4 Jan 2026 (estimated)
- Primary completionJul 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PICUStudies of the same condition, open and under way.
- More trials run by Mansoura UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- The study will include a convenience sample comprising of all nurses available and on duty in the PICU (who directly handled HAM
- Masking
- None (open label)
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mansoura University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07320196
- Sponsor's protocol ID
- Mind Map high alert medication
- Acronym
- HAMs- PICU
- Status last verified
- Sep 2025
- First submitted
- 8 Sep 2025
- Last updated
- 6 Jan 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No individual participant data (IPD) will be shared because the study involves sensitive clinical data from a small population, and sharing may pose confidentiality risks despite de-identification. Access Criteria: Not applicable. IPD will not be shared.
Study at a glance
From the registry record, last updated by the sponsor on 6 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effectiveness of Smart Mind Maps in Promoting Safe Administration of High-Alert Medications Among Nurses in the Pediatric Intensive Care Unit
- ClinicalTrials.gov ID
- NCT07320196
- Acronym / sponsor ID
- HAMs- PICU / Mind Map high alert medication
- Keywords
- HAMs, PICU, Nurses, Safe administration
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Mansoura UniversityUniversity, hospital or other
- Study start
- 4 Jan 2026 (estimated)
- Primary completion
- Jul 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 6 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In PICU setting, drug administration, monitoring, and prescribing errors made up most cases (54%) of MEs . Emphasizes these issues requires a multifaceted approach, including staff training, creation of innovative cognitive frameworks, use of electronic prescribing systems, and the promotion of a safety-awareness within healthcare settings. Recently, mind mapping has been applied in the field of nursing education as an advanced conceptual tool. It uses a technique of combining drawings with words to build memory associations between a topic keyword and image, color, or other link allowing learners to effectively store and extract information
Detailed description
This study aims to evaluate the effectiveness of smart mind maps in promoting safe administration of high-alert medications among nurses in the pediatric intensive care unit. Designing a mind map using AI holds significant value for nurses working in the PICU. AI-powered mind maps can help nurses organize complex patient information more efficiently, enabling quicker decision-making and improved care planning. By integrating AI, the mind map can automatically update with real-time data, alert nurses to critical changes, and even suggest evidence-based interventions. This not only enhances patient safety and care quality but also reduces cognitive load and streamlines communication among the healthcare team .
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- The study will include a convenience sample comprising of all nurses available and on duty in the PICU (who directly handled HAM
| Arm | Type | Receives |
|---|---|---|
| one group pretest/post test | Experimental | Other: smart mind mapsdePICU nurses who directly handled HAM |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Nurses on duty in the PICU (who directly handled HAM) irrespectively to their age, sex, educational level.
Key exclusion criteria (1 listed)
- Nurses who do not handle with HAM
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| smart mind mapsdedesigning a smart mind maps as an advanced conceptual tool to help nurses understand well about HAMs | Other | one group pretest/post test |
Primary outcome
Tool I: A Structured Assessment Questionnaire
Time frame: 2 weeks
It will be developed by the researcher which will consist of two parts: Part 1: Socio-demographic Characteristics and Professional Data of Studied Nurses part 2: Knowledge Assessment Tool on AI and Mind Mapping for Nurses (pre/posttest)
Tool II: Nurses' Knowledge Regarding Safe Use of High-Alert Medications (HAMs)
Time frame: 1 month
It will be developed to collect data necessary for evaluating nurses' knowledge related to safe use of high-alert medications. The assessment will encompass key domains such as the definition and classification of HAMs, safety precautions during drug administration (including delivery routes and dosage accuracy), and drug regulation (including proper storage, documentation, and handling procedures).
Tool III: Observational Checklist for Safe Handling of High Alert Medications
Time frame: 2 month
It will be developed by the researcherto objectively assess nurses' practices related to the safe handling of high-alert medications in PICUs according to the international recognized guidelines and evidence-based protocols.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jan 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No. No individual participant data (IPD) will be shared because the study involves sensitive clinical data from a small population, and sharing may pose confidentiality risks despite de-identification. Access Criteria: Not applicable. IPD will not be shared.
Related trials for PICU
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Not yet recruitingObservational study
Platelet Transfusion Thresholds in Non-Bleeding Patients
Non Bleeding Patients With Thrombocytopenia
Active, not recruiting
PICU Up!: A Pilot Stepped-wedge Trial of a Multicomponent Early Mobility Intervention for Critically Ill Children
Critical Illness
Not yet recruiting
Building Resilience Through Anxiety Virtual Education in PICU Survivors
Critical Illness Recovery, Mental Health
Not yet recruitingObservational study
A Cohort Study on Anti-microbial Stewardship in PICU
Infections
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
doaa osman ibrahim doaa ibrahim- assistant lecturer, assistant lecturer contact
Questions about this trial
What is this clinical trial studying?
A study testing smart mind mapsde in people with PICU and Nurses, run by Mansoura University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 6 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact doaa osman ibrahim doaa ibrahim- assistant lecturer, assistant lecturer (020-01069637084, doaaibrahim93@mans.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Tool I: A Structured Assessment Questionnaire (time frame: 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2026.